Trial Profile
A Phase 2 Study of HC-58 in Patients With Severe Upper Limb Hemiplegia After Stroke
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Elcatonin (Primary)
- Indications Hemiplegia
- Focus Therapeutic Use
- Sponsors Asahi Kasei
- 13 Feb 2017 Status changed from active, no longer recruiting to completed.
- 08 May 2015 New trial record